Site‐Selective Synthesis of NH ‐Pyrazolo[3,4‐ b ]pyridines via Copper‐Catalyzed Alkenylation of NH ‐3‐Aminopyrazoles with Styrene Oxides
Advanced Synthesis & Catalysis · 19.05.2026 · 368 (10)
DOI: 10.1002/adsc.70512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 20.05.2026. Verfasst von Xiaohong Liu und 6 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
A convenient and efficient protocol has been developed for the synthesis of pharmaceutically privileged NH ‐pyrazolo[3,4‐ b ]pyridines from readily available aldehydes, styrene oxides, and NH ‐3‐aminopyrazoles. This work discloses a site‐selective annulation strategy in which NH ‐3‐aminopyrazoles serve as N′/C‐4 dinucleophiles, rather than the conventional N′/N‐2 mode, enabled by copper‐catalyzed C−H alkenylation with styrene oxides. The operationally simple transformation exhibits broad functional group tolerance and good scalability, as further demonstrated by the late‐stage functionalization of clinically relevant drug molecules.
Zitieren
APA
Liu, X., Li, M., Qin, X., Cao, P., Zhu, H., Hu, P., & Gao, Q. (2026). Site‐Selective Synthesis of NH ‐Pyrazolo[3,4‐ b ]pyridines via Copper‐Catalyzed Alkenylation of NH ‐3‐Aminopyrazoles with Styrene Oxides. Advanced Synthesis & Catalysis, 368(10). https://doi.org/10.1002/adsc.70512
Vancouver
Liu X, Li M, Qin X, Cao P, Zhu H, Hu P, et al. Site‐Selective Synthesis of NH ‐Pyrazolo[3,4‐ b ]pyridines via Copper‐Catalyzed Alkenylation of NH ‐3‐Aminopyrazoles with Styrene Oxides. Advanced Synthesis & Catalysis. 2026;368(10). doi:10.1002/adsc.70512
BibTeX
@article{Liu2026,
author = {Liu, Xiaohong and Li, Mengjie and Qin, Xiaofei and Cao, Penghui and Zhu, Huaiyuan and Hu, Peng and Gao, Qinghe},
title = {Site‐Selective Synthesis of NH ‐Pyrazolo[3,4‐ b ]pyridines via Copper‐Catalyzed Alkenylation of NH ‐3‐Aminopyrazoles with Styrene Oxides},
journal = {Advanced Synthesis & Catalysis},
year = {2026},
volume = {368},
number = {10},
doi = {10.1002/adsc.70512}
}
EUVIMED